<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font23 { font-size : 23; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">influenza </span>
   <span class="font23">vaccine </span>
   <span class="font15">virus </span>
   <span class="font15">[]. </span>
   <span class="font14">vaccines </span>
   <span class="font12">universal </span>
   <span class="font12">production </span>
   <span class="font12">strains </span>
   <span class="font12">protection </span>
   <span class="font12">immune </span>
   <span class="font12">egg-based </span>
   <span class="font12">human </span>
   <span class="font12">{border-style </span>
   <span class="font11">immunity </span>
   <span class="font11">monoglycosylated </span>
   <span class="font11">px;} </span>
   <span class="font11">response </span>
   <span class="font11">split </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">conserved </span>
   <span class="font11">recombinant </span>
   <span class="font11">antigenic </span>
   <span class="font11">Influenza </span>
   <span class="font11">[], </span>
   <span class="font11">antibodies </span>
   <span class="font11">attenuated </span>
   <span class="font11">LAIV </span>
   <span class="font11">challenge </span>
   <span class="font11">high </span>
   <span class="font11">viruses </span>
   <span class="font11">circulating </span>
   <span class="font11">flu </span>
   <span class="font11">hemagglutinin </span>
   <span class="font11">inactivated </span>
   <span class="font11">pandemic </span>
   <span class="font11">site </span>
   <span class="font11">Vaccine </span>
   <span class="font11">seasonal </span>
   <span class="font11">shown </span>
   <span class="font11">strain </span>
   <span class="font11">Infect </span>
   <span class="font11">cell-based </span>
   <span class="font11">current </span>
   <span class="font11">efficacy </span>
   <span class="font11">single </span>
   <span class="font11">viral </span>
   <span class="font10">binding </span>
   <span class="font10">developed </span>
   <span class="font10">domain </span>
   <span class="font10">elicit </span>
   <span class="font10">glycosylation </span>
   <span class="font10">similar </span>
   <span class="font10">stem </span>
   <span class="font10">HA, </span>
   <span class="font10">HAI </span>
   <span class="font10">However, </span>
   <span class="font10">N-glycans </span>
   <span class="font10">antibody </span>
   <span class="font10">based </span>
   <span class="font10">head </span>
   <span class="font10">higher </span>
   <span class="font10">live </span>
   <span class="font10">multiple </span>
   <span class="font10">new </span>
   <span class="font10">novel </span>
   <span class="font10">protein </span>
   <span class="font10">px; </span>
   <span class="font10">sites </span>
   <span class="font10">strategy </span>
   <span class="font10">subtypes </span>
   <span class="font10">trivalent </span>
   <span class="font10">{font-family </span>
   <span class="font10">HAmg </span>
   <span class="font10">Health </span>
   <span class="font10">I/II </span>
   <span class="font10">[â€“] </span>
   <span class="font10">cell </span>
   <span class="font10">cells </span>
   <span class="font10">clinical </span>
   <span class="font10">currently </span>
   <span class="font10">different </span>
   <span class="font10">drift </span>
   <span class="font10">effective </span>
   <span class="font10">epitopes </span>
   <span class="font10">escape </span>
   <span class="font10">font-size </span>
   <span class="font10">group </span>
   <span class="font10">induces </span>
   <span class="font10">mannose </span>
   <span class="font10">phase </span>
   <span class="font10">protective </span>
   <span class="font10">replication </span>
   <span class="font10">responses </span>
   <span class="font10">results </span>
   <span class="font10">type </span>
   <span class="font10">Acad </span>
   <span class="font10">HN, </span>
   <span class="font10">N-glycosylation </span>
   <span class="font10">Natl </span>
   <span class="font10">SRH </span>
   <span class="font10">age </span>
   <span class="font10">assays </span>
   <span class="font10">conventional </span>
   <span class="font10">development </span>
   <span class="font10">double; </span>
   <span class="font10">effectiveness </span>
   <span class="font10">elderly </span>
   <span class="font10">embryonated </span>
   <span class="font10">from: </span>
   <span class="font10">host </span>
   <span class="font10">immunization </span>
   <span class="font10">increase </span>
   <span class="font10">induce </span>
   <span class="font10">inoculation </span>
   <span class="font10">neutralizing </span>
   <span class="font10">potential </span>
   <span class="font10">pre-existing </span>
   <span class="font10">produced </span>
   <span class="font10">recent </span>
   <span class="font10">receptor </span>
   <span class="font10">resulting </span>
   <span class="font10">traditional </span>
   <span class="font10">vaccination </span>
   <span class="font10">.collab: </span>
   <span class="font10">Academia </span>
   <span class="font10">Available </span>
   <span class="font10">DNA </span>
   <span class="font10">Global </span>
   <span class="font10">IIV </span>
   <span class="font10">MSR </span>
   <span class="font10">National </span>
   <span class="font10">Organization </span>
   <span class="font10">Research </span>
   <span class="font10">adults </span>
   <span class="font10">annual </span>
   <span class="font10">antigenicity </span>
   <span class="font10">approval </span>
   <span class="font10">assay </span>
   <span class="font10">better </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">candidate </span>
   <span class="font10">chicken </span>
   <span class="font10">criteria </span>
   <span class="font10">diverse </span>
   <span class="font10">ectodomain </span>
   <span class="font10">elicited </span>
   <span class="font10">glycoprotein </span>
   <span class="font10">healthy </span>
   <span class="font10">include </span>
   <span class="font10">induced </span>
   <span class="font10">insect </span>
   <span class="font10">intranasal </span>
   <span class="font10">low </span>
   <span class="font10">major </span>
   <span class="font10">mice </span>
   <span class="font10">mucosal </span>
   <span class="font10">mutations </span>
   <span class="font10">next-generation </span>
   <span class="font10">process </span>
   <span class="font10">provide </span>
   <span class="font10">provides </span>
   <span class="font10">regulatory </span>
   <span class="font10">respiratory </span>
   <span class="font10">safety </span>
   <span class="font10">season </span>
   <span class="font10">solid; </span>
   <span class="font10">strains, </span>
   <span class="font10">surface </span>
   <span class="font10">using </span>
   <span class="font10">vaccine. </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Fig. </span>
   <span class="font10">A./pnas. </span>
   <span class="font10">Center </span>
   <span class="font10">Committee </span>
   <span class="font10">Immunization </span>
   <span class="font10">Institute </span>
   <span class="font10">Live </span>
   <span class="font10">Phase </span>
   <span class="font10">Response </span>
   <span class="font10">Sci </span>
   <span class="font10">Sinica </span>
   <span class="font10">Surveillance </span>
   <span class="font10">United </span>
   <span class="font10">Virol./JVI.- </span>
   <span class="font10">Virol./JVI...-. </span>
   <span class="font10">World </span>
   <span class="font10">advantages </span>
   <span class="font10">al.A </span>
   <span class="font10">antigenically </span>
   <span class="font10">antigens </span>
   <span class="font10">applicable. </span>
   <span class="font10">bold </span>
   <span class="font10">broadly </span>
   <span class="font10">cell-mediated </span>
   <span class="font10">cells, </span>
   <span class="font10">cellular </span>
   <span class="font10">challenges </span>
   <span class="font10">changes </span>
   <span class="font10">courier; </span>
   <span class="font10">data </span>
   <span class="font10">disease </span>
   <span class="font10">does </span>
   <span class="font10">drifted </span>
   <span class="font10">egg </span>
   <span class="font10">egg-adapted </span>
   <span class="font10">eggs </span>
   <span class="font10">em; </span>
   <span class="font10">evolution </span>
   <span class="font10">expression </span>
   <span class="font10">ferrets </span>
   <span class="font10">generated </span>
   <span class="font10">global </span>
   <span class="font10">glycan </span>
   <span class="font10">glycans </span>
   <span class="font10">humoral </span>
   <span class="font10">immunogenicity </span>
   <span class="font10">including </span>
   <span class="font10">monoglycosylation </span>
   <span class="font10">nanoparticle </span>
   <span class="font10">placebo-controlled </span>
   <span class="font10">platform </span>
   <span class="font10">population </span>
   <span class="font10">preclinical </span>
   <span class="font10">previous </span>
   <span class="font10">provided </span>
   <span class="font10">pt;} </span>
   <span class="font10">recognition </span>
   <span class="font10">recommendations </span>
   <span class="font10">recommended </span>
   <span class="font10">remains </span>
   <span class="font10">responses, </span>
   <span class="font10">role </span>
   <span class="font10">sequence </span>
   <span class="font10">sequences </span>
   <span class="font10">sialic </span>
   <span class="font10">significant </span>
   <span class="font10">strain-specific </span>
   <span class="font10">strategies </span>
   <span class="font10">studies </span>
   <span class="font10">suitable </span>
   <span class="font10">synthetic </span>
   <span class="font10">time </span>
   <span class="font10">trial </span>
   <span class="font10">use </span>
   <span class="font10">vaccine, </span>
   <span class="font10">vaccine: </span>
   <span class="font10">vaccines: </span>
  </p>
 </body>
</html>
